Specify a stock or a cryptocurrency in the search bar to get a summary
K Pharma
4896K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan. Address: Tri-Seven Roppongi, Minato-ku, Japan, 106-0032
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4896
Dividend Analytics 4896
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4896
Stock Valuation 4896
Financials 4896
Results | 2019 | Dynamics |